Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03418025 · ClinicalTrials.gov registry record · NA

Exercising Together During Radiation Treatment

A NA study of Prostate Carcinoma and Spouse, sponsored by OHSU Knight Cancer Institute.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT03418025: Completed NA study of Prostate Carcinoma and Spouse, sponsored by OHSU Knight Cancer Institute.

NCT03418025 is a NA study of Prostate Carcinoma and Spouse that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 24 participants, below the 1,501-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03418025, a NA study of Prostate Carcinoma and Spouse, has completed, sponsored by OHSU Knight Cancer Institute.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This pilot clinical trial studies how well the Exercising Together program works in helping couples cope with radiation treatment for prostate cancer. Treatments for cancer can cause side effects for the patient, such as fatigue, add stress for the spousal caregiver, and put strain on the marital relationship. The Exercising Together program is designed to promote teamwork and emotional intimacy during exercise, which itself can help manage fatigue and stress for the patient and spouse, and may facilitate communication between partners about day-to-day energy, abilities, and motivation.

Primary Outcome

Will be determined as the number of couples who enroll out of those approached and the number of couples who opt to participate in Exercising Together versus to participate as controls. Will evaluate using descriptive statistics.

Interventions

  • OTHER Survey Administration
  • OTHER Questionnaire Administration
  • BEHAVIORAL Exercise Intervention

Study Locations (1)

Oregon

  • OHSU Knight Cancer Institute - Portland

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2017-11-01
Est. Completion 2018-10-23
Phase NA
OHSU Knight Cancer Institute

211 total trials

What the finished NCT03418025 record still lists

NCT03418025 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,501-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Prostate Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.

NCT03418025 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT03418025 about?

NCT03418025 is a clinical study titled "Exercising Together During Radiation Treatment". This pilot clinical trial studies how well the Exercising Together program works in helping couples cope with radiation treatment for prostate cancer. Treatments for cancer can cause side effects for the patient, such as fatigue, add stress for the spousal caregiver, and put strain on the marital re...

What is the current status of trial NCT03418025?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2017-11-01. Estimated completion is 2018-10-23.

What conditions does trial NCT03418025 study?

This clinical trial studies the following conditions: Prostate Carcinoma, Spouse, Domestic Partnership.

What interventions are being tested in trial NCT03418025?

The interventions under investigation include: Survey Administration (OTHER), Questionnaire Administration (OTHER), Exercise Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03418025?

This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03418025 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03418025's enrollment target sits among peer trials

24 53rd of 59 higher than 7 of 59 other Prostate Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03418025, the US trial registry maintained by the National Library of Medicine. NCT03418025 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.